Fig. 1From: High lymphocyte population-related predictive factors for a long-term response in non-small cell lung cancer patients treated with pemetrexed: a retrospective observational studyPatient enrollment process. 381 NSq-NSCLC patients treated with PEM regimen or PTX regimen were finally enrolled, divided into three groups by treatment cycles. NSCLC = Non-small cell lung carcinoma, PEM = Pemetrexed, PTX = PaclitaxelBack to article page